No definition available.
Congenital malformations of cardiac chambers and connections
Q17_CONGEN_MALFO_CARDIAC_CHAMB_CONNECTIO
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
227 |
4. Check minimum number of eventsNone |
227 |
5. Include endpointsNone |
227 |
6. Filter based on genotype QC (FinnGen only) |
227 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_CIRCULATO_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q2
- Name in latin
- Malformationes congenitae loculorum et connectionum cordis
Similar endpoints
↥List of similar endpoints to
Congenital malformations of cardiac chambers and connections
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of heart and great arteries
- Congenital malformations of the circulatory system
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1715 | 717 | 996 |
| Only index persons | 1148 | 491 | 657 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.03 |
| Only index persons | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 2.36 | 3.16 | 1.67 |
| Only index persons | 8.28 | 9.82 | 7.14 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 227 | 97 | 130 |
| Unadjusted period prevalence (%) | 0.05 | 0.03 | 0.06 |
| Median age at first event (years) | 8.78 | 9.12 | 8.52 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 200
- Matched controls
- 1999
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q20.3
ICD-10 Finland
Discordant ventriculoarterial connection
+∞
121.6
104
*
201
Kela drug reimbursment
Chronic cardiac insufficiency
301.0
118.0
110
8
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
330.6
116.4
108
7
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
138.9
108.0
109
17
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
39.6
92.4
123
77
XF404
NOMESCO Finland
Ambulatory ECG
44.7
88.7
112
55
C03CA01
ATC
furosemide; systemic
38.8
84.4
111
62
C03DA01
ATC
spironolactone; oral
66.7
81.1
92
25
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
202.0
77.3
76
6
XF400
NOMESCO Finland
ECG with 12 standard connections
21.3
76.5
135
177
B01AA03
ATC
warfarin; systemic
48.5
76.4
93
35
XF402
NOMESCO Finland
ECG with work load test
45.6
73.0
90
35
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
155.4
70.3
71
7
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
19.9
68.0
116
129
C01AA05
ATC
digoxin; systemic
127.0
59.9
62
7
GD1AA
NOMESCO Finland
Thorax X-ray examination
13.4
59.5
149
357
ZXE20
NOMESCO Finland
More than three and less than five hours
16.9
59.4
107
127
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
+∞
58.2
53
*
Q20.1
ICD-10 Finland
Double outlet right ventricle
+∞
58.2
53
*
TPH07
NOMESCO Finland
Cathetrisation of artery
20.1
58.1
94
84
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
20.5
56.9
91
78
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
+∞
55.9
51
*
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
131.5
55.2
57
6
ZXD10
NOMESCO Finland
Scheduled procedure
12.5
54.8
159
473
Z2221
NOMESCO Finland
Medical doctor
11.3
53.0
145
377
Q20.48
ICD-10 Finland
Single ventricle
+∞
51.3
47
*
FM2CE
NOMESCO Finland
NA
21.6
49.6
76
55
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
+∞
49.0
45
*
31
HP
Congenital heart failure surgery
+∞
46.7
43
*
61
HP
Catheterization and pressure measurement of the left side of the heart
+∞
46.7
43
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
35.8
45.8
59
23
Q21.10
ICD-10 Finland
Persistent ostium secundum
+∞
45.6
42
*
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
522.0
44.0
42
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
11.5
43.3
92
137
ZXE10
NOMESCO Finland
More than one and less than three hours
8.6
43.0
137
402
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
181.1
42.6
43
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
84.5
42.1
46
7
WX408
NOMESCO Finland
General anesthesy, balanced
8.4
41.9
131
369
XF622
NOMESCO Finland
Measurement of minute volume of heart
+∞
39.9
37
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
16.4
39.1
66
58
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
+∞
37.7
35
*
62
HP
Catheterization and pressure measurement of the right side of the heart
+∞
36.6
34
*
XF600
NOMESCO Finland
Bloodpressure measurement
10.7
35.2
75
106
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
+∞
34.3
32
*
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
+∞
33.2
31
*
G04BE03
ATC
sildenafil; oral
196.0
32.7
33
*
ZXD05
NOMESCO Finland
Urgent procedure
6.4
31.8
113
337
WX404
NOMESCO Finland
Intravenous generell anesthesy
6.4
31.1
107
303
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
81.2
31.0
34
5
Z98.8
ICD-10 Finland
Other specified postsurgical states
98.2
30.8
33
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
16.7
30.5
50
39
ZXE40
NOMESCO Finland
More than seven and less than nine hours
24.5
30.3
43
22
Q21.30
ICD-10 Finland
Tetralogy of Fallot
+∞
29.9
28
*
Q25.1
ICD-10 Finland
Coarctation of aorta
+∞
29.9
28
*
207
Kela drug reimbursment
Chronic arrhythmias
30.8
28.7
38
15
C09AA02
ATC
enalapril; systemic
13.6
28.4
51
49
R4110
NOMESCO Finland
Physiotherapy
5.7
27.9
106
328
74619
ICD-8 Finland
Congenital anomalies of heart, Transposition of great vessels
+∞
27.7
26
*
C01BD01
ATC
amiodarone; systemic
310.0
27.4
27
*
TFP20
NOMESCO Finland
Cardiodefibrillation
54.0
27.4
32
7
FBE10
NOMESCO Finland
Expansion or reconstruction of pulmonary artery using patch
+∞
26.6
25
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
20.7
26.1
39
23
WX892
NOMESCO Finland
Monitored bed care
10.9
25.9
52
62
ZXE00
NOMESCO Finland
One hour or less
5.1
25.8
135
578
Q25.0
ICD-10 Finland
Patent ductus arteriosus
+∞
25.5
24
*
7451A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Transposition of great vessels[TRANSPOSITIO CORDIS COMPLETA]
+∞
24.5
23
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
9.7
24.2
52
70
Q20.5
ICD-10 Finland
Discordant atrioventricular connection
+∞
23.4
22
*
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
46.0
23.3
28
7
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
59.3
22.7
26
5
WX882
NOMESCO Finland
High dependency care
7.2
22.6
60
112
C07AB07
ATC
bisoprolol; oral
5.9
21.8
70
167
Q20.40
ICD-10 Finland
Double inlet left ventricle
+∞
21.2
20
*
5255
FHL
Deep hypothermia (<20 °) with cardiopulmonary resuscitation
+∞
21.2
20
*
I49.5
ICD-10 Finland
Sick sinus syndrome
232.9
21.0
21
*
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
+∞
20.1
19
*
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
45.0
20.0
24
6
Z3231
NOMESCO Finland
Registered nurse
4.1
19.9
116
499
Q20.8
ICD-10 Finland
Other congenital malformations of cardiac chambers and connections
+∞
19.0
18
*
Q20.00
ICD-10 Finland
Common arterial trunk
+∞
19.0
18
*
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
+∞
19.0
18
*
Q22.0
ICD-10 Finland
Pulmonary valve atresia
+∞
19.0
18
*
FBJ10
NOMESCO Finland
Anastomosis to pulmonary artery from subclavian artery with interposition graft
+∞
19.0
18
*
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
208.5
18.9
19
*
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
208.5
18.9
19
*
I50.9
ICD-10 Finland
Heart failure, unspecified
17.8
18.1
28
18
FBE32
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery
+∞
18.0
17
*
ZX120
NOMESCO Finland
Intravenous
6.6
17.5
48
91
WX872
NOMESCO Finland
Intensive care
19.7
17.5
26
15
I47.1
ICD-10 Finland
Supraventricular tachycardia
12.4
17.2
31
29
FAE00
NOMESCO Finland
Anastomosis to pulmonary artery from superior vena cava
+∞
16.9
16
*
WX704
NOMESCO Finland
Intubation
8.5
16.5
37
52
XFE00
NOMESCO Finland
Epicardial ultrasonography
23.4
16.4
23
11
7AX01
NOMESCO Finland
NA
52.1
16.3
19
*
C07AA07
ATC
sotalol; systemic
52.1
16.3
19
*
C09AA05
ATC
ramipril; oral
8.8
16.0
35
47
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
21.4
16.0
23
12
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
+∞
15.8
15
*
FAE10
NOMESCO Finland
Bidirectional anastomosis between superior vena cava and pulmonary artery
+∞
15.8
15
*
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
+∞
15.8
15
*
ZX199
NOMESCO Finland
Other rote
22.2
15.5
22
11
Q25.41
ICD-10 Finland
Persistent right-sided aortic arch
+∞
14.8
14
*
FPF20
NOMESCO Finland
Implantation of epicardial pacemaker with atrial and ventricular electrodes
+∞
14.8
14
*
Q22.41
ICD-10 Finland
Tricuspid atresia
+∞
14.8
14
*
I37.0
ICD-10 Finland
Pulmonary valve stenosis
+∞
14.8
14
*
Q23.0
ICD-10 Finland
Congenital stenosis of aortic valve
+∞
14.8
14
*
Q21.21
ICD-10 Finland
Atrioventricular duct
+∞
14.8
14
*
TPH04
NOMESCO Finland
Cathetrisation of vein
4.2
14.1
61
190
C07AB02
ATC
metoprolol; systemic
6.7
13.8
36
63
XF640
NOMESCO Finland
NA
80.7
13.8
15
*
Q26.1
ICD-10 Finland
Persistent left superior vena cava
+∞
13.7
13
*
Q24.0
ICD-10 Finland
Dextrocardia
+∞
13.7
13
*
XF620
NOMESCO Finland
Examination of circulation with color method
+∞
13.7
13
*
FXA20
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure
+∞
13.7
13
*
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
+∞
13.7
13
*
Q23.11
ICD-10 Finland
Bicuspid aortic valve
+∞
13.7
13
*
FDB20
NOMESCO Finland
Arterial switch operation for other congenital heart defect
+∞
13.7
13
*
FJF20
NOMESCO Finland
Replacement of pulmonary valve using homograft
+∞
13.7
13
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
28.0
13.6
18
7
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.0
13.4
60
191
I44.2
ICD-10 Finland
Atrioventricular block, complete
34.5
12.8
16
5
C02EA02
ATC
NA
+∞
12.6
12
*
Q23.3
ICD-10 Finland
Congenital mitral insufficiency
+∞
12.6
12
*
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
+∞
12.6
12
*
7451B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Transposition of great vessels[DOUBLE OUTLET RIGHT VENTRICLE]
+∞
12.6
12
*
FJD20
NOMESCO Finland
Bypass of pulmonary valve with ventriculopulmonary prosthesis or homograft
+∞
12.6
12
*
FBE35
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery with insertion of stent
+∞
12.6
12
*
XQ903
NOMESCO Finland
Production of other scan or drawing
138.1
12.6
13
*
AN1
HP
Coronary angiography
23.0
12.2
17
8
Z3226
NOMESCO Finland
Physiotherapist
3.3
12.2
77
320
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.9
12.0
54
171
Z94.1
ICD-10 Finland
Heart transplant status
32.2
11.8
15
5
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
69.0
11.7
13
*
Q21.31
ICD-10 Finland
Tetralogy of Fallot and double outlet right ventricle
+∞
11.6
11
*
74639
ICD-8 Finland
Congenital anomalies of heart, Defectus septi ventriculorum
+∞
11.6
11
*
I37.1
ICD-10 Finland
Pulmonary valve insufficiency
+∞
11.6
11
*
AP2
HP
Catheterization of the right side of the heart
+∞
11.6
11
*
Q24.4
ICD-10 Finland
Congenital subaortic stenosis
+∞
11.6
11
*
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
+∞
11.6
11
*
Q25.40
ICD-10 Finland
Aortic hypoplasia
+∞
11.6
11
*
Q25.6
ICD-10 Finland
Stenosis of pulmonary artery
+∞
11.6
11
*
FPH00
NOMESCO Finland
Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator
+∞
11.6
11
*
ZX108
NOMESCO Finland
Inhalation
15.1
11.2
18
13
RS224
NOMESCO Finland
NA
16.7
11.0
17
11
I50.0
ICD-10 Finland
Congestive heart failure
29.9
10.9
14
5
FN1CD
NOMESCO Finland
Very extensive CT of coronary arteries
63.4
10.7
12
*
R07.4
ICD-10 Finland
Chest pain, unspecified
3.8
10.6
48
152
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
5.8
10.5
30
59
1EA01
NOMESCO Finland
NA
115.7
10.5
11
*
Q24.3
ICD-10 Finland
Pulmonary infundibular stenosis
+∞
10.5
10
*
I28.8
ICD-10 Finland
Other specified diseases of pulmonary vessels
+∞
10.5
10
*
TFP45
NOMESCO Finland
Ablation treatment of non-typical atrial flutter
+∞
10.5
10
*
Q21.0
ICD-10 Finland
Ventricular septal defect
+∞
10.5
10
*
Q20.9
ICD-10 Finland
Congenital malformation of cardiac chambers and connections, unspecified
+∞
10.5
10
*
B34.9
ICD-10 Finland
Viral infection, unspecified
6.1
10.3
28
52
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
10.1
61
240
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
21.3
9.9
14
7
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.9
9.6
72
324
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
7.1
9.6
23
36
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
9.4
9.5
19
22
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
23.0
9.5
13
6
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
23.0
9.5
13
6
FHB50
NOMESCO Finland
Transatrial closure of VSD using patch
+∞
9.4
9
*
Q20.60
ICD-10 Finland
Left isomerism of atrial appendages
+∞
9.4
9
*
FBA96
NOMESCO Finland
Other suture or repair of pulmonary artery
+∞
9.4
9
*
3A077
NOMESCO Finland
NA
+∞
9.4
9
*
FM1BD
NOMESCO Finland
Extensive CT of heart
+∞
9.4
9
*
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
+∞
9.4
9
*
FHE30
NOMESCO Finland
Repair of tetralogy of Fallot with transannular patch
+∞
9.4
9
*
ZSF00
NOMESCO Finland
Procedure related to previous procedure classified in chapter F
+∞
9.4
9
*
Q23.10
ICD-10 Finland
Congenital insufficiency of aortic valve
+∞
9.4
9
*
7454A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM NUD]
+∞
9.4
9
*
Q21.19
ICD-10 Finland
Atrial septal defect NOS
+∞
9.4
9
*
UGC02
NOMESCO Finland
Rigid bronchoscopy
16.6
9.2
14
9
I50.1
ICD-10 Finland
Left ventricular failure
19.7
9.1
13
7
205
Kela drug reimbursment
Chronic hypertension
5.0
8.8
28
63
Z01.8
ICD-10 Finland
Other specified special examinations
3.2
8.7
51
195
602
Kela drug reimbursment
Children's severe malnutrition
5.8
8.6
24
46
RK260
NOMESCO Finland
NA
21.1
8.6
12
6
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
93.7
8.5
9
*
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
93.7
8.5
9
*
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
93.7
8.5
9
*
FM1CD
NOMESCO Finland
Very extensive CT of heart
93.7
8.5
9
*
XG460
NOMESCO Finland
Short time oxymetry
93.7
8.5
9
*
Q21.9
ICD-10 Finland
Congenital malformation of cardiac septum, unspecified
+∞
8.4
8
*
7453B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Common ventricle[COMMON VENTRICLE]
+∞
8.4
8
*
74629
ICD-8 Finland
Congenital anomalies of heart, Tetralogy of Fallot
+∞
8.4
8
*
Q24.9
ICD-10 Finland
Congenital malformation of heart, unspecified
+∞
8.4
8
*
324
NOMESCO Finland
NA
+∞
8.4
8
*
FFE02
NOMESCO Finland
Percutaneous transluminal atrial septostomy
+∞
8.4
8
*
Q25.78
ICD-10 Finland
Other congenital malformations of pulmonary artery
+∞
8.4
8
*
FJF10
NOMESCO Finland
Replacement of pulmonary valve using biological prosthesis
+∞
8.4
8
*
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
+∞
8.4
8
*
Q24.8
ICD-10 Finland
Other specified congenital malformations of heart
+∞
8.4
8
*
74689
ICD-8 Finland
Congenital anomalies of heart, Aliae definitae
+∞
8.4
8
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
12.4
8.2
14
12
TFP35
NOMESCO Finland
Electroanatomical mapping
34.8
8.1
10
*
WX402
NOMESCO Finland
General anaesthesia
2.7
7.9
61
276
Z2446
NOMESCO Finland
Social worker
2.9
7.9
53
220
WX002
NOMESCO Finland
Sedation and analgesia
3.6
7.8
36
115
1CX08
NOMESCO Finland
NA
46.8
7.8
9
*
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
46.8
7.8
9
*
Q20.41
ICD-10 Finland
Double inlet right ventricle
+∞
7.3
7
*
AF1
HP
Surgery of congenital heart defect
+∞
7.3
7
*
Q25.21
ICD-10 Finland
Interrupted aortic arch
+∞
7.3
7
*
FXA13
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and exclusive cerebral perfusion
+∞
7.3
7
*
FM1DM
NOMESCO Finland
Heart very extensive MRI examination with 3 Tesla magnet
+∞
7.3
7
*
K83
ICPC
Heart valve disease NOS
+∞
7.3
7
*
7471A
ICD-9 Finland
Other congenital anomalies of circulatory system, Coarctation of aorta[COARCTATIO AORTAE]
+∞
7.3
7
*
AP3
HP
Catheterization of the right and left side of the heart
+∞
7.3
7
*
74709
ICD-8 Finland
Other congenital anomalies of circulatory system, Patent ductus arteriosus
+∞
7.3
7
*
Q21.18
ICD-10 Finland
Other spedified atrial septal defect
+∞
7.3
7
*
FFK20
NOMESCO Finland
Atrio-pulmonary anastomosis
+∞
7.3
7
*
Q22.40
ICD-10 Finland
Congenital tricuspid stenosis
+∞
7.3
7
*
FAE30
NOMESCO Finland
Total cavo-pulmonary connection using fenestrated patch
+∞
7.3
7
*
7460C
ICD-9 Finland
Other congenital anomalies of heart, Anomalies of pulmonary valve[VITIUM VALVULAE PULMONALIS CONGENITA CUM STENOSIS]
+∞
7.3
7
*
I37.2
ICD-10 Finland
Pulmonary valve stenosis with insufficiency
+∞
7.3
7
*
R50.9
ICD-10 Finland
Fever, unspecified
2.6
7.3
60
279
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
4.6
7.2
24
57
WX870
NOMESCO Finland
Other postsurgical intensive care
31.2
7.2
9
*
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
31.2
7.2
9
*
J01CA04
ATC
amoxicillin; systemic
3.7
7.2
186
1558
B01AB05
ATC
enoxaparin; parenteral
3.3
7.2
36
123
R04.0
ICD-10 Finland
Epistaxis
5.7
7.0
19
36
TFP34
NOMESCO Finland
Electrophysiological investigation
9.8
6.9
13
14
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.4
6.9
24
60
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.4
6.8
73
390
I47.2
ICD-10 Finland
Ventricular tachycardia
17.4
6.8
10
6
K84
ICPC
Heart disease other
41.4
6.8
8
*
GD1LA
NOMESCO Finland
GD
23.4
6.7
9
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
5.4
6.7
19
38
I47.9
ICD-10 Finland
Paroxysmal tachycardia, unspecified
12.8
6.7
11
9
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
12.8
6.7
11
9
5253
FHL
Cardiac lung machine
71.9
6.5
7
*
ZXA00
NOMESCO Finland
Right side
2.8
6.5
43
177
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.0
6.3
19
41
Q25.3
ICD-10 Finland
Stenosis of aorta
+∞
6.3
6
*
5401
FHL
Pacemaker installation, transvenous electrode
+∞
6.3
6
*
Q22.6
ICD-10 Finland
Hypoplastic right heart syndrome
+∞
6.3
6
*
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
+∞
6.3
6
*
Q20.4
ICD-10 Finland
Double inlet ventricle
+∞
6.3
6
*
Q21.32
ICD-10 Finland
Pulmonary atresia with Fallot ventricular septal defect
+∞
6.3
6
*
7454B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM SIMPLEX]
+∞
6.3
6
*
Q21.3
ICD-10 Finland
Tetralogy of Fallot
+∞
6.3
6
*
I97.0
ICD-10 Finland
Postcardiotomy syndrome
+∞
6.3
6
*
7452A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Tetralogy of Fallot[TETRALOGIA FALLOT]
+∞
6.3
6
*
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
+∞
6.3
6
*
3A566
NOMESCO Finland
NA
+∞
6.3
6
*
Q22.2
ICD-10 Finland
Congenital pulmonary valve insufficiency
+∞
6.3
6
*
7468X
ICD-9 Finland
Other congenital anomalies of heart, Other specified anomalies of heart[MUU SYDÄMEN EPÄMUODOSTUMA]
+∞
6.3
6
*
FBJ00
NOMESCO Finland
Anastomosis to pulmonary artery from subclavian artery
+∞
6.3
6
*
5233
FHL
Right ventricular bypass surgery (Fontan et al.)
+∞
6.3
6
*
FJD96
NOMESCO Finland
Other operation on right ventricle outlet for congenital or acquired obstruction
+∞
6.3
6
*
7452B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Tetralogy of Fallot[DOUBLE OUTLET RIGHT VENTRICLE AND PULMONAL STENOSIS]
+∞
6.3
6
*
I48.4
ICD-10 Finland
Atypical atrial flutter
+∞
6.3
6
*
7461A
ICD-9 Finland
Other congenital anomalies of heart, Tricuspid atresia and stenosis, congenital[VITIUM VALVULAE TRICUSPIDALIS CONGENITUM CUM ATRESI]
+∞
6.3
6
*
TFJ02
NOMESCO Finland
Muscle biopsy of heart
27.6
6.3
8
*
I44.1
ICD-10 Finland
Atrioventricular block, second degree
27.6
6.3
8
*
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
5.9
6.1
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
155
50
95.58
259.38
6.8
7.0
ng/l
156.2
164.8
0.05
146
44
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
119
187
12.27
81.85
7.7
3.3
ng/l
3164.5
212.3
2.18
104
99
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
61
32
25.70
80.87
4.0
6.3
%
73.3
100.2
3.11
61
32
(3032080) INR in Blood by Coagulation assay
156
354
11.89
78.49
19.8
5.2
inr
2.0
1.1
7.43
29
107
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
56
34
21.54
69.16
17.5
20.7
u/ml
0.3
0.3
0.10
40
22
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
72
99
10.19
52.93
5.8
8.6
%
179.9
167.8
0.52
72
99
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
101
207
7.99
52.43
3.8
3.1
%
20.4
23.9
1.65
92
197
(3004789) Transferrin [Mass/volume] in Serum or Plasma
102
224
7.45
49.15
4.0
3.0
g/l
2.5
2.5
0.64
102
216
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
127
346
7.06
49.05
4.2
3.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
141
429
7.04
48.24
14.2
8.3
%
66.8
90.7
21.76
141
423
(3044640) Blood type and Crossmatch panel - Blood
137
429
6.53
44.67
4.4
3.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
41
39
12.61
38.68
1.5
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
101
295
5.37
34.00
5.7
4.6
mg/l
1.9
1.2
0.92
77
214
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
101
295
5.37
34.00
5.6
3.0
ng/l
34.4
24.7
0.37
63
138
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
147
611
4.99
31.14
5.3
4.7
—
—
—
0
0
(3044889) 12 lead EKG panel
167
784
5.28
29.75
6.6
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
45
74
7.34
27.45
34.6
9.6
inr
2.3
1.2
—
9
15
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
40
61
7.75
26.05
32.0
25.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
106
392
4.20
25.03
4.0
3.6
mg/l
3.6
2.6
1.19
99
347
(3042936) Bacteria identified in Isolate by Culture
68
183
4.88
24.35
3.3
2.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
50
110
5.55
22.54
29.9
18.0
mmol/l
0.1
0.2
0.08
45
93
(3023368) Bacteria identified in Blood by Culture
87
299
4.10
22.38
8.1
4.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
57
150
4.74
20.73
2.2
1.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
220
1647
11.88
20.29
40.8
13.5
mmol/l
4.0
4.0
2.64
220
1589
(3019550) Sodium [Moles/volume] in Serum or Plasma
220
1647
11.88
20.29
40.6
13.4
mmol/l
139.2
139.5
1.48
220
1595
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
38
77
5.73
18.58
37.7
17.8
%
0.7
0.7
0.72
38
77
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
38
77
5.73
18.58
37.7
17.8
%
1.1
1.2
0.47
38
77
(3000991) Gas panel - Venous blood
83
313
3.60
18.10
23.7
12.8
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
15
10
15.99
16.91
1.7
2.3
%
170.3
124.1
—
15
10
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
88
370
3.25
15.80
26.4
16.5
mmol/l
25.5
24.6
1.63
88
370
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
16
14
12.22
15.48
1.6
2.1
%
129.1
124.4
0.08
16
14
(3002032) Base excess in Venous blood by calculation
83
343
3.24
15.26
9.4
11.3
mmol/l
1.1
1.1
0.03
69
265
(3024928) Oxygen saturation in Venous blood
26
44
6.54
15.15
7.4
22.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
55
182
3.67
14.30
2.9
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
116
604
2.88
13.83
9.5
10.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
54
182
3.58
13.61
3.2
1.9
—
—
—
0
0
(3009343) pH of Capillary blood
79
340
3.03
13.29
20.2
10.3
ph
7.4
7.4
—
5
10
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
79
340
3.03
13.29
20.0
10.3
mmol/l
1.8
0.9
2.37
67
253
(3022313) Gas panel - Capillary blood
72
295
3.11
13.19
20.6
10.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
79
342
3.01
13.13
20.2
10.2
kpa
5.2
5.1
0.57
79
329
(3028626) Oxygen [Partial pressure] in Capillary blood
72
301
3.04
12.67
20.2
10.4
kpa
8.7
9.7
2.73
72
290
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
59
228
3.15
11.82
3.3
2.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
14
15
9.88
11.77
6.3
2.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
135
805
2.67
11.74
10.1
10.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
18
27
7.15
11.64
2.9
2.9
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
23
45
5.57
11.53
7.7
20.9
%
75.6
72.4
0.43
23
45
(3051611) Lipemic interference index of Serum or Plasma
18
28
6.90
11.27
3.3
3.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
220
1843
7.28
11.23
25.6
8.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
55
223
2.94
10.00
2.1
1.9
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
13
5
27.42
9.92
2.9
13.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
13
5
27.42
9.92
2.9
13.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
20
40
5.39
9.76
2.2
2.3
g/l
1.0
1.1
0.06
15
35
(3003694) ABO and Rh group [Type] in Blood
97
539
2.40
9.19
1.6
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
154
1052
2.44
9.00
11.6
9.9
e9/l
0.6
0.6
0.91
142
872
(3006315) Basophils [#/volume] in Blood
154
1052
2.44
9.00
11.6
9.9
e9/l
0.0
0.0
0.62
142
873
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
48
4.72
8.82
2.2
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
37
128
3.26
8.77
1.4
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
17
33
5.49
8.55
7.3
27.6
%
12.8
11.9
0.52
17
33
(3013115) Eosinophils [#/volume] in Blood
155
1080
2.37
8.39
12.5
10.9
e9/l
0.2
0.2
1.39
143
919
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
160
1143
2.35
7.97
23.3
7.9
ml/min/173m2
100.8
101.0
0.04
135
836
(3019198) Lymphocytes [#/volume] in Blood
154
1084
2.31
7.93
11.7
10.0
e9/l
1.7
2.3
10.99
143
928
(3021589) Normoblasts [#/volume] in Blood
144
989
2.25
7.83
13.6
11.8
e9/l
0.0
0.0
0.76
122
747
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
12
18
6.98
7.68
1.2
1.2
%
80.6
94.9
0.52
12
18
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
33
5.14
7.53
1.4
1.2
u/ml
7.0
2.9
—
8
15
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
16
33
5.14
7.53
1.4
1.2
u/ml
1.5
1.6
—
6
16
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
70
3.72
7.35
2.7
2.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
61
3.89
7.22
3.3
2.9
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
10
13
8.00
7.17
2.3
1.1
%
57.0
115.5
—
10
13
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
10
13
8.00
7.17
1.1
1.5
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
11
8
14.36
6.96
1.6
1.3
umol/l
13.0
9.0
—
11
8
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
11
8
14.36
6.96
1.1
1.1
%
80.3
100.8
—
11
8
(4306422)
13
24
5.68
6.85
1.3
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
20
54
3.96
6.80
9.9
12.5
mmol/l
22.5
23.7
1.12
20
49
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
20
54
3.96
6.80
1.5
5.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
21
59
3.82
6.77
2.1
2.1
—
—
—
0
0
(4268621)
12
21
5.98
6.66
2.3
2.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
71
3.49
6.48
4.1
2.4
ml/min/173m2
68.3
88.2
—
10
26
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
23
73
3.39
6.21
2.7
2.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
155
1154
2.08
6.13
13.5
13.0
e9/l
3.7
3.6
0.33
146
962
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
213
1821
3.75
6.11
30.5
11.5
mg/l
24.2
21.9
0.50
175
1270
(3024932) HLA-DR beta [Type]
12
23
5.45
6.08
1.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
31
4.75
6.07
1.3
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
9
6
15.54
5.95
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
12
24
5.22
5.81
1.0
1.0
—
—
—
0
0
(3013512) EKG study
44
210
2.36
5.58
9.8
2.7
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
18
53
3.60
5.43
1.4
5.2
%
44.3
68.8
3.88
18
53
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
23
81
3.05
5.26
2.5
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
6
13.75
5.11
1.4
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
12
27
4.64
5.10
3.1
6.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
23
4.98
5.07
1.7
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
215
1890
3.60
5.02
43.6
14.9
%
40.0
40.3
0.33
203
1685
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
51
3.52
4.99
2.1
2.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
7
11.78
4.82
1.3
2.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
87
575
1.83
4.48
4.8
4.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
83
541
1.84
4.47
4.5
4.5
e6/l
26.2
37.7
0.30
64
408
(44790047)
16
50
3.37
4.43
2.9
2.3
—
—
—
0
0
(44790049)
16
50
3.37
4.43
2.9
2.3
—
—
—
0
0
(44806118)
16
50
3.37
4.43
2.9
2.3
—
—
—
0
0
(44790048)
16
50
3.37
4.43
2.9
2.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
79
509
1.85
4.40
4.5
4.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
211
0.22
4.24
1.0
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
93
638
1.78
4.17
5.1
5.3
e6/l
9.9
31.2
1.22
65
422
(3019060) Gas panel - Arterial blood
15
47
3.35
4.13
2.9
14.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
69
2.91
4.13
16.4
11.8
iu/ml
1796.0
425.3
—
5
12
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
42
3.49
4.11
3.4
2.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
77
504
1.80
4.02
4.7
4.3
e6/l
0.5
0.3
0.64
58
370
(3021901) Oxygen saturation in Capillary blood
12
33
3.78
3.98
5.8
8.6
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
16
54
3.11
3.93
1.3
4.7
e9/l
0.3
0.2
0.65
11
38
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
57
342
1.89
3.91
2.9
3.8
e6/l
2.2
1.6
0.31
30
205
(3034988) Calcium [Moles/volume] in Capillary blood
8
11
7.49
3.89
8.9
10.7
mmol/l
1.2
1.2
—
8
11
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
29
3.94
3.85
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
72
2.79
3.84
1.8
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
72
2.79
3.84
1.8
1.3
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
15
50
3.14
3.76
1.3
4.9
%
13.9
27.7
5.32
15
50
(3018418) pH of Serum or Plasma
58
356
1.85
3.70
8.0
3.8
ph
7.4
7.4
—
10
48
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
21
87
2.56
3.59
3.0
2.7
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
9
17
5.46
3.54
7.4
8.4
mg/l
125.2
67.1
—
9
17
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
55
339
1.82
3.44
3.1
3.8
e6/l
0.5
0.6
0.03
28
201
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
9
18
5.16
3.40
8.2
13.1
mg/l
2.5
2.1
—
9
13
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
23
103
2.37
3.35
1.6
1.9
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
15
54
2.90
3.32
14.1
5.6
%
53.1
63.2
0.62
15
54
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
38
3.28
3.26
1.7
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
22
98
2.38
3.25
1.9
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
39
3.19
3.14
1.9
1.3
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
15
56
2.80
3.12
1.5
5.2
%
40.3
14.4
3.05
15
56
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
62
2.70
3.12
9.3
12.7
—
2462.3
—
0
10
(3002179) Metamyelocytes/100 leukocytes in Blood
22
101
2.30
3.04
4.2
6.0
%
0.8
0.4
—
5
27
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
21
4.42
3.03
1.4
1.8
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
5
10.18
2.99
1.4
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
160
1815
0.60
2.95
3.9
3.9
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
7
13
5.52
2.89
12.6
1.5
mmol/l
1.7
1.3
—
7
13
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
31
3.33
2.81
1.9
5.3
%
56.3
49.3
—
10
31
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
72
2.47
2.80
2.4
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
22
105
2.21
2.79
2.8
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
48
713
0.59
2.75
1.5
1.8
u/ml
0.3
3.0
—
6
132
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
49
2.75
2.67
1.4
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
20
4.11
2.59
1.5
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
39
2.91
2.51
1.9
2.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
16
4.48
2.49
2.6
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
21
105
2.10
2.40
4.7
6.4
%
0.0
0.1
—
7
34
(40768441) Liver Pathology biopsy report
7
17
4.21
2.38
1.1
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
21
106
2.08
2.34
2.9
1.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
121
2.00
2.30
1.5
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
22
114
2.03
2.30
4.9
6.0
%
1.1
0.6
—
7
40
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
13
4.71
2.28
1.8
1.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
8
24
3.42
2.20
4.1
24.1
mmol/l
1.2
1.3
—
8
18
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
55
2.45
2.16
1.5
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
55
0.00
2.10
0.0
6.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
31
2.98
2.09
1.9
5.1
e9/l
4.7
3.0
—
9
31
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
56
0.00
2.09
0.0
2.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
29
171
1.80
2.09
4.7
5.4
e9/l
83.4
64.4
1.10
21
112
(3038515) Glucose [Moles/volume] in Venous blood
5
10
5.08
2.08
15.0
1.5
mmol/l
8.3
6.1
—
5
10
(3021788) Differential panel - Synovial fluid
5
10
5.08
2.08
2.4
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
51
2.43
1.98
2.2
2.6
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
7
21
3.40
1.98
7.3
5.5
kpa
4.8
5.0
—
7
21
(3027315) Oxygen [Partial pressure] in Blood
7
21
3.40
1.98
7.4
5.5
kpa
7.5
8.9
—
7
21
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
52
2.38
1.91
2.0
1.8
—
—
—
0
0
(3020891) Body temperature
10
40
2.57
1.86
4.8
7.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
46
318
1.56
1.84
3.7
2.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
12
4.23
1.83
1.4
2.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
12
4.23
1.83
2.4
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
19
103
1.92
1.78
4.9
6.5
%
0.0
0.1
—
5
32
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
89
1.98
1.75
9.1
4.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
46
0.00
1.73
0.0
1.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
47
0.00
1.72
0.0
2.0
—
6.4
—
0
16
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
47
0.00
1.72
0.0
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
12
55
2.25
1.70
1.4
5.2
—
—
—
0
0
(4034850)
8
31
2.64
1.67
4.0
6.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
29
184
1.66
1.64
1.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
14
3.63
1.62
1.6
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
14
3.63
1.62
1.6
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
14
3.63
1.62
1.6
2.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
8
32
2.55
1.61
2.1
3.2
g/l
141.1
129.5
—
8
26
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
85
1.95
1.59
1.3
1.4
—
—
—
0
0
(3010421) pH of Blood
7
26
2.74
1.59
7.4
4.7
ph
7.4
7.4
—
7
21
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
125
0.39
1.55
1.6
1.3
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
10
45
2.28
1.48
1.8
1.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
9
38
2.42
1.47
1.3
2.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
44
317
1.48
1.46
1.9
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
59
2.09
1.46
1.2
1.3
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
10
47
2.18
1.36
1.0
1.0
g/l
156.2
163.7
—
10
47
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
38
0.00
1.35
0.0
6.1
—
1.7
—
0
38
(3016018) Differential panel - Cerebral spinal fluid
0
41
0.00
1.32
0.0
6.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
48
359
1.43
1.32
6.6
5.9
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
11
55
2.05
1.29
1.3
4.8
e6/l
448.3
447.1
—
6
35
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
116
0.42
1.29
1.2
1.4
—
—
—
0
0
(4094501)
5
18
2.82
1.29
1.6
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
35
480
0.68
1.29
2.1
2.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
63
1.96
1.25
1.5
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
25
2.44
1.25
5.0
6.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
168
0.52
1.24
1.4
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
56
2.01
1.24
1.1
3.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
34
0.00
1.17
0.0
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
34
0.00
1.17
0.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
34
0.00
1.17
0.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
31
2.30
1.11
1.4
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
124
0.47
1.08
1.2
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
18
114
1.63
1.06
2.3
2.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
22
2.30
1.04
1.6
2.3
g/l
0.0
0.0
—
5
22
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
22
2.30
1.04
1.6
2.3
g/l
0.0
0.0
—
5
22
(4035726)
16
100
1.65
0.99
4.1
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
16
100
1.65
0.99
1.0
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
23
2.20
0.98
1.6
2.3
g/l
0.0
0.0
—
5
23
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
12
69
1.78
0.98
4.6
3.9
mmol/l
1.3
1.2
0.79
12
57
(36660697) Celiac disease serology panel - Serum
23
324
0.68
0.98
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
12
71
1.73
0.90
4.1
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
29
2.10
0.90
2.2
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
121
1085
1.25
0.89
5.2
4.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
8
43
1.89
0.88
1.1
3.9
—
536.4
—
0
5
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
197
1.42
0.87
2.0
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
44
1.85
0.87
1.3
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
32
1.90
0.82
1.0
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
24
174
1.42
0.81
3.4
2.7
u/l
31.9
33.1
0.06
19
147
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
41
507
0.77
0.79
1.6
1.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
26
0.00
0.79
0.0
1.6
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
53
1.73
0.76
2.7
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
39
1.82
0.73
1.4
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
25
2.02
0.73
1.6
2.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
27
1.87
0.69
1.8
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
53
447
1.24
0.66
2.3
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
131
0.60
0.65
1.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
10
153
0.64
0.65
1.4
1.3
iu/ml
85.9
166.3
—
5
51
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
138
0.64
0.63
1.7
2.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
3.1
—
171.7
—
0
6
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
11
72
1.55
0.60
4.6
4.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
217
0.72
0.58
1.2
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
55
1.47
0.56
1.8
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
204
0.72
0.56
3.4
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
43
506
0.81
0.55
4.3
3.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
38
1.59
0.54
1.5
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
203
0.72
0.54
2.9
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
15
203
0.72
0.54
2.9
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
49
419
1.22
0.54
3.7
3.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
39
1.55
0.53
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
15
202
0.72
0.53
3.0
1.7
—
—
—
0
0
(4010399)
12
83
1.47
0.53
2.3
1.5
—
—
—
0
0
(3000492) Spirometry study
22
171
1.32
0.52
1.5
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
18
234
0.75
0.51
1.2
1.3
iu/ml
10.0
19.0
—
6
59
(3016879) Cocaine [Presence] in Urine
14
189
0.72
0.50
2.9
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
117
1254
0.86
0.50
3.4
2.8
mmol/l
5.5
5.6
0.56
110
1163
(3022145) Colonoscopy Study observation
7
110
0.62
0.49
1.7
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
16
210
0.74
0.49
1.5
1.4
—
33.1
—
0
8
(3023511) Choriogonadotropin [Units/volume] in Urine
10
68
1.49
0.47
1.3
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
116
0.68
0.47
1.1
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
50
1.41
0.45
7.3
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
131
0.67
0.44
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
162
0.73
0.44
3.3
1.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
14
184
0.75
0.44
2.0
2.1
nmol/l
13.2
13.3
0.02
14
159
(3041096) Erythrocytes [Presence] in Urine by Automated
32
378
0.82
0.43
3.6
2.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
31
1.63
0.43
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
35
409
0.83
0.42
1.8
2.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
32
1.57
0.42
6.0
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
16
205
0.76
0.42
1.8
1.8
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
33
1.53
0.41
5.8
4.9
umol/l
22.0
27.3
—
5
33
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
15
0.00
0.41
0.0
2.3
—
74.0
—
0
10
(3026389) Candida sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
8.9
—
0.6
—
0
15
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.5
—
12.6
—
0
5
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
16
0.00
0.41
0.0
7.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
16
0.00
0.41
0.0
7.0
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
0.7
—
0
10
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
2.3
—
0
11
(3011288) Drugs identified in Urine by Screen method
10
137
0.72
0.40
4.4
2.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
8.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
3.1
—
757.7
—
0
18
(4027681)
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.0
—
250.5
—
0
19
(3019832) Treponema pallidum Ab [Presence] in Serum
29
341
0.83
0.38
1.8
1.8
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
37
1.36
0.37
1.6
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
49
435
1.16
0.37
2.0
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
41
1.48
0.36
2.2
2.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
25
211
1.21
0.33
1.2
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
133
1268
1.12
0.33
4.3
3.0
mmol/l
1.3
1.3
0.02
126
1204
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
10
131
0.75
0.31
2.3
2.2
—
5.8
—
0
6
(3007164) IgA [Mass/volume] in Serum or Plasma
63
685
0.89
0.31
1.6
1.8
g/l
1.8
1.7
0.21
45
367
(3050129) First trimester maternal screen panel - Serum or Plasma
8
106
0.75
0.29
1.6
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
30
342
0.86
0.29
3.9
3.0
kg/l
1.0
1.0
—
6
56
(3036481) Cortisol [Moles/volume] in Serum or Plasma
27
235
1.17
0.27
3.3
2.8
nmol/l
353.0
337.6
0.15
27
222
(46235355) HIV 1 and 2 tests - Meaningful Use set
61
563
1.11
0.26
2.1
2.1
—
—
—
0
0
(1002224) Polysomnography panel
5
71
0.70
0.26
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
137
0.79
0.25
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
20
171
1.19
0.24
1.4
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21
242
0.85
0.23
1.7
2.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
40
363
1.12
0.23
1.9
1.6
pmol/l
86.7
96.6
0.82
24
193
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
39
1.29
0.23
1.8
2.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.1
—
26.9
—
0
10
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.7
—
2.7
—
0
10
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
2.0
—
0
8
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
6.7
—
0
14
(3029075) Extractable nuclear Ab panel - Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
51
1.18
0.19
5.2
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
41
444
0.91
0.19
1.9
2.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
37
340
1.11
0.18
4.1
3.6
estimate
0.2
0.0
0.47
13
119
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
152
0.85
0.17
1.3
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
82
1.23
0.17
1.7
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
67
0.74
0.17
1.0
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
5
68
0.73
0.17
2.4
2.0
nmol/l
1.8
0.4
—
5
59
(3005033) Fetal Nuchal fold Thickness US
5
68
0.73
0.17
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
68
0.73
0.17
1.4
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
69
0.72
0.17
1.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
70
0.71
0.17
1.4
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
79
0.75
0.16
1.0
1.7
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
6
79
0.75
0.16
1.8
1.3
nmol/l
44.8
31.9
—
6
79
(3037522) Nuclear Ab [Titer] in Serum
23
253
0.90
0.14
1.3
1.5
titre
240.0
420.5
—
6
43
(3012516) Albumin [Mass/volume] in Urine
22
238
0.92
0.10
4.0
4.0
mg/l
142.6
139.2
0.01
17
175
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
135
1326
1.04
0.09
4.3
3.2
mmol/l
2.6
2.8
1.88
128
1251
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
67
1.05
0.08
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
134
1319
1.04
0.07
4.3
3.1
mmol/l
1.2
1.4
7.35
129
1250
(3003327) Ova and parasites identified in Stool by Light microscopy
10
112
0.89
0.07
1.7
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
85
1.06
0.07
1.3
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
16
172
0.92
0.06
1.6
2.7
ug/l
0.5
1.2
5.23
11
160
(3009261) Glucose [Presence] in Urine by Test strip
74
756
0.97
0.05
4.1
3.4
estimate
0.0
0.0
0.00
12
115
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
149
1506
0.97
0.05
4.7
4.0
mu/l
2.2
1.9
1.83
142
1416
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
128
1292
0.98
0.03
4.2
3.7
pmol/l
15.7
14.4
6.29
121
1200
(40761536) Microorganisms panel - Urine sediment
12
112
1.08
0.03
4.3
3.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
74
750
0.98
0.02
5.7
5.0
estimate
0.0
0.0
0.00
14
123
(3020682) Albumin/Creatinine [Ratio] in Urine
23
238
0.96
0.02
4.1
4.7
mg/mmol
25.3
15.7
0.35
18
173
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
74
746
0.99
0.00
1.9
1.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
115
1146
1.01
0.00
4.0
3.8
mmol/mol
35.2
37.8
4.10
110
1093
(3035350) Ketones [Presence] in Urine by Test strip
75
749
1.00
0.00
4.1
3.3
estimate
0.0
0.0
0.00
14
118
(3015736) pH of Urine
61
608
1.00
0.00
3.5
3.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
10
97
1.03
0.00
1.0
1.0
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
10
97
1.03
0.00
1.0
1.0
mmol/l
21.6
19.2
—
10
97
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
79
0.88
0.00
1.6
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
74
0.94
0.00
1.0
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
79
0.88
0.00
1.6
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
78
0.89
0.00
1.3
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4024509)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(4146454)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
6.2
—
18.3
—
0
5
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
79
0.88
0.00
1.6
1.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
96
0.93
0.00
4.0
2.0
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
8
79
1.01
0.00
7.5
6.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
4.4
—
4.0
—
0
5
(3041806) Other cells [#/volume] in Blood by Manual count
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009410) PHENobarbital [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.0
—
105.8
—
0
5
(3002523) Influenza virus A Ag [Presence] in Specimen
7
79
0.88
0.00
1.3
1.2
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
69.5
—
0
7
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
79
0.88
0.00
1.6
1.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
1.2
—
21.7
—
0
6
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
138.2
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
74.0
—
0
5
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
69
1.01
0.00
1.0
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
4.7
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
2019.0
—
0
5
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_CARDIAC_CHAMB_CONNECTIO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_CARDIAC_CHAMB_CONNECTIO | 9.355 [4.38, 19.97] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.586 |
During the follow-up period (1.1.1998 — 31.12.2019), 74 out of 576 females with Q17_CONGEN_MALFO_CARDIAC_CHAMB_CONNECTIO died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_CARDIAC_CHAMB_CONNECTIO | 7.222 [4.72, 11.04] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 88 out of 760 males with Q17_CONGEN_MALFO_CARDIAC_CHAMB_CONNECTIO died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_CARDIAC_CHAMB_CONNECTIO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.913% | 1.304% |
| 5 | 6.522% | 6.938% |
| 10 | 15.52% | 17.531% |
| 15 | 25.751% | 31.095% |
| 20 | 40.699% | 46.393% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_CARDIAC_CHAMB_CONNECTIO – Congenital malformations of cardiac chambers and connections
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data